| NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 17 (8), 896-909, 2019 | 233 | 2019 |
| Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target U Saini, S Naidu, AC ElNaggar, HK Bid, JJ Wallbillich, K Bixel, C Bolyard, ... Oncogene 36 (2), 168-181, 2017 | 116 | 2017 |
| HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer KS Rath, SK Naidu, P Lata, HK Bid, BK Rivera, GA McCann, BJ Tierney, ... Cancer research 74 (8), 2316-2327, 2014 | 80 | 2014 |
| Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial A Oaknin, CF Friedman, LD Roman, A D'Souza, I Brana, FC Bidard, ... Gynecologic oncology 159 (1), 150-156, 2020 | 45 | 2020 |
| Risk factors for anal intraepithelial neoplasia in women with genital dysplasia AC ElNaggar, JT Santoso Obstetrics & gynecology 122 (2 PART 1), 218-223, 2013 | 40 | 2013 |
| Perioperative outcomes for laparotomy compared to robotic surgical staging of endometrial cancer in the elderly: a retrospective cohort FJ Backes, AC ElNaggar, MR Farrell, LA Brudie, S Ahmad, R Salani, ... International Journal of Gynecologic Cancer 26 (9), 2016 | 29 | 2016 |
| Establishment of a molecular tumor board (MTB) and uptake of recommendations in a community setting A VanderWalde, A Grothey, D Vaena, G Vidal, A ElNaggar, G Bufalino, ... Journal of Personalized Medicine 10 (4), 252, 2020 | 27 | 2020 |
| Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer JY Hou, JS Chapman, E Kalashnikova, W Pierson, K Smith-McCune, ... Gynecologic Oncology 167 (2), 334-341, 2022 | 21 | 2022 |
| Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center AC ElNaggar, EM Hade, DM O'Malley, MI Liang, LJ Copeland, JM Fowler, ... Gynecologic Oncology 151 (3), 501-505, 2018 | 18 | 2018 |
| Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients KC Fuh, AA Secord, KS Bevis, W Huh, A ElNaggar, K Blansit, R Previs, ... Gynecologic oncology 139 (3), 413-418, 2015 | 18 | 2015 |
| Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer AC ElNaggar, U Saini, S Naidu, R Wanner, M Sudhakar, J Fowler, ... Cancer biology & therapy 17 (10), 1107-1115, 2016 | 17 | 2016 |
| Endometrial cancer in a 15-year-old girl: A complication of Cowden Syndrome AC ElNaggar, SL Spunt, W Smith, M Depas, JT Santoso Gynecologic Oncology Case Reports 3, 18-19, 2013 | 15 | 2013 |
| Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis K Cadoo, F Simpkins, C Mathews, YL Liu, D Provencher, C McCormick, ... Gynecologic oncology 166 (3), 425-431, 2022 | 14 | 2022 |
| Human papilloma virus infection and anal squamous intraepithelial lesions LS López, L La Rosa Clinics in Colon and Rectal Surgery 32 (05), 347-357, 2019 | 14 | 2019 |
| Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center MI Liang, AC ElNaggar, S Nekkanti, DM O'Malley, EM Hade, LJ Copeland, ... Gynecologic oncology 138 (3), 689-693, 2015 | 14 | 2015 |
| Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: an open-label randomized control trial MA Ulm, AC ElNaggar, TD Tillmanns Gynecologic Oncology 151 (1), 124-128, 2018 | 13 | 2018 |
| Molecular profiles of endometrial cancer tumors among Black patients AM Wilhite, Y Baca, J Xiu, R Paladugu, AC ElNaggar, J Brown, IS Winer, ... Gynecologic oncology 166 (1), 108-116, 2022 | 12 | 2022 |
| COM701 with or without nivolumab: Results of an ongoing phase 1 study of safety, tolerability and preliminary antitumor activity in patients with advanced solid malignancies … DA Vaena, GF Fleming, B Chmielowski, M Sharma, EP Hamilton, ... Journal of Clinical Oncology 39 (15_suppl), 2504-2504, 2021 | 12 | 2021 |
| Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy A ElNaggar, D Robins, Y Baca, D Arguello, M Ulm, R Arend, ... Gynecologic Oncology 167 (2), 306-313, 2022 | 9 | 2022 |
| Ovarian cancer, version 1.2019 featured updates to the nccn guidelines DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 17 (8), 896-909, 2019 | 9 | 2019 |
Shan Naidu, DVM, PhD, DACVPPathologistVerified email at modernatx.com
